Latest news
{{'2026-02-05T15:46:04Z' | dateFormatFilter}}
Novo Nordisk issues statement on illegal mass compounding and deceptive advertising by Hims & Hers
{{'2026-02-04T14:53:59Z' | dateFormatFilter}}
Novo Nordisk files annual report with the SEC
{{'2026-02-04T07:00:42Z' | dateFormatFilter}}
Novo Nordisk initiates 2026 share repurchase programme
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
